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OBJECTIVE: The aim of this study was to evaluate the effect of a novel phytoestrogen, a-Zearalanol, on
Alzheimer’s disease-related memory impairment and neuronal oxidation in ovariectomized mice.
METHODS: Female C57/BL6 mice were ovariectomized or received sham operations and treatment with
equivalent doses of 17b-estradiol or a-Zearalanol for 8 weeks. Their spatial learning and memory were analyzed
using the Morris water maze test. The antioxidant enzyme activities and reactive oxygen species generation,
neuronal DNA oxidation, and MutT homolog 1 expression in the hippocampus were measured.
RESULTS: Treatment with 17b-estradiol or a-Zearalanol significantly improved spatial learning and memory
performance in ovariectomized mice. In addition, 17b-estradiol and a-Zearalanol attenuated the decrease in
antioxidant enzyme activities and increased reactive oxygen species production in ovariectomized mice. The
findings indicated a significant elevation in hippocampi neuronal DNA oxidation and reduction in MutT
homolog 1 expression in estrogen-deficient mice, but supplementation with 17b-estradiol or a-Zearalanol
efficaciously ameliorated this situation.
CONCLUSION: These results demonstrate that a-Zearalanol is potentially beneficial for improving memory
impairments and neuronal oxidation damage in a manner similar to that of 17b-estradiol. Therefore, the
compound may be a potential therapeutic agent that can ameliorate neurodegenerative disorders related to
estrogen deficiency.
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& INTRODUCTION
In addition to the regulation of reproductive functions,
estrogens may exert several neuroprotective effects on the
brain. Estrogens may facilitate axonal sprouting, neuronal
repair, and neurogenesis induction (1), and they may also
reduce reactive oxygen species (ROS)-related neuronal
damage and protect neuronal nucleic acids against the
detrimental consequences of oxidative stress (2). These
beneficial effects have led to the use of estrogen replacement
therapy as an effective method to reduce the risk and
severity of Alzheimer’s disease (AD) in postmenopausal
women, who are burdened with a higher incidence of AD
than men of the same age and premenopausal women (3-5).
However, the fact that estrogen replacement therapy may
predispose women to a much higher incidence of breast
and endometrial cancers has undoubtedly compromised or
jeopardized the clinical application of estrogen (6). Thus, the
search for safe and effective estrogen substitutes has gained
increased importance.
Recently, plant-derived phytoestrogens (which possess
the physiological properties of animal-derived estrogen)
have been demonstrated to act as potential replacements
for estrogen. In our previous study, we confirmed the
neuroprotective effect of the phytoestrogen a-Zearalanol
(a-ZAL), and it was demonstrated to have low side-effects
on the reproductive system compared with animal-derived
estrogen (7). a-ZAL is a reductive product of Gibberella zeae
metabolites that is abundant in plants and vegetables,
including soybeans, wheat, grapes, radishes, celery, spi-
nach, and apples (8), and can be safely metabolized in the
body (9). Our previous reports implied that a-ZAL could
provide a beneficial effect on the maintenance of the
oxidant-antioxidant balance (10,11). This effect thereby
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allows a-ZAL to apparently ameliorate the neuron damage
induced by oxidative stress. Recent results have suggested
that the oxidative damage of DNA plays a meaningful role
in the pathogenesis of AD (12,13), and estrogen deficiency
supplementation appears to provide a powerful protective
effect against DNA oxidation, which contributes to the
improvement of AD-related cognitive deficits (14,15).
However, whether a-ZAL exerts the same influence on
cognition and neuronal oxidation remains unclear. In the
present study, we investigated the effect of a-ZAL on
memory impairment and neuronal DNA oxidation in
estrogen-deficient mice and the underlying molecular
mechanisms, with 17b-estradiol (E2) serving as an estro-
gen-positive control.
& MATERIALS AND METHODS
Materials
a-ZAL was a gift from Prof. Shunling Dai at Perking
Union Medical College. E2, 2’,7’-dichlorofluorescein diace-
tate (DCFH-DA), and RNase were purchased from Sigma-
Aldrich (Saint Louis, MO, USA). The protease inhibitor
mixture and BCA Protein Assay Kit were obtained from
Pierce Biotechnology (Rockford, IL, USA). The reagent kits
used for the measurement of superoxide dismutase (SOD)
and glutathione peroxidase (GSH-Px) were purchased
from Nanjing Jiancheng Bioengineering Institute (Nanjing,
China). In addition, 8-oxo-7,8-dihydrodeoxyguanosine (8-
oxoguanine) and MutT homolog 1 (MTH1) antibodies were
purchased from Abcam (Abcam, England). b-actin antibody
was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). The avidin-biotin-peroxidase and DAB kits used
for immunohistochemical detection were obtained from
Zhongshang Goldenbridge Biotechnology (Beijing, China).
All other chemicals used were of the highest commercial
grade available.
Animals and treatment
Female C57/BL6 mice (8 weeks old) were purchased from
Weitong Lihua Experimental Animal Center (Beijing,
China). All of the mice were housed in groups of 5 on a
12-hour light/dark schedule. The mice were allowed free
access to mouse lab chow and water. Animal treatment and
maintenance were conducted in accordance with the
guidelines established by the National Institutes of Health
for the care and use of laboratory animals and were
approved by the Animal Care Committee of the Peking
Union Medical College and the Chinese Academy of
Medical Science.
After 5 days of habituation, the animals were anesthetized
with ketamine (100 mg/kg) and xylazine (20 mg/kg), and a
bilateral ovariectomy (OVX) or sham-operation was per-
formed. Following surgery, the mice were allowed to
recover for 14 days and then assigned to one of the
following four groups (n = 10 in each group): control group,
Sham-operation+ olive oil; OVX group, OVX+olive oil; E2
group, OVX+E2; and a-ZAL group, OVX+a-ZAL. Mice in
the E2 and a-ZAL groups received intraperitoneal (i.p.)
injections of E2 (0.5 mg/kg) and a-ZAL (0.5 mg/kg),
respectively. The E2 and a-ZAL chemicals were dissolved
in olive oil. Mice in the control group and OVX group
received an equal volume of olive oil. The intraperitoneal
injections were administered every three days. Treatment
continued for 8 weeks. The above animal treatment
procedures were conducted as described previously in a
paper by our group (7).
Morris water maze
The method used for training and testing mice in the
Morris water maze was similar to that previously described
(16). The animals were trained in a water tank (100 cm in
diameter) located in a lit room with visual cues. A black
escape platform (9.5 cm in diameter) was submerged 1 cm
below the water surface in the middle of the southwest
quadrant of the tank. The water was maintained at 21¡1 C˚
and mixed with milk powder to obscure the platform. The
test began on the 52nd day after injection. The Morris water
maze protocol consisted of a 4-day learning and memory
training period and a probe test on day 5. For each training
trial, each mouse was randomly placed in the water, facing
the tank wall, at one of the four starting points (the
midpoints of the four quadrants of the tank) and was
allowed a maximum time of 60 s to find the platform. Mice
that found the platform were allowed to remain on the
platform for 10 s and subsequently placed into an empty
and warm cage for 15 min before the next trial began. If a
mouse did not reach the platform within 60 s, it was gently
guided to the platform by the experimenter, where it
remained for 10 s. Four training trials were conducted each
day for 4 consecutive days. After 4 days of trials, the probe
test was conducted by removing the platform and allowing
each mouse to swim freely for 60 s inside the tank. The
time spent in the southwest quadrant (explore time;
location where the platform was originally placed), the
escape latency (time to reach the original platform
position), and the swimming speed were recorded by a
video camera and computer system and subsequently
analyzed by a computer (the hardware and software were
provided by HVS IMAGE P.O. Box 100, Hampton TW12
2YD, UK).
Sample preparation
After the behavioral tests, six animals in each group were
deeply anesthetized by isoflurane inhalation and sacrificed
by decapitation. The brain was removed and dissected on
ice. The hippocampus was removed and stored at -80 C˚ for
Western blotting and biochemical analysis. The remaining
4 animals were perfused with phosphate-buffered saline
(PBS) and 4% paraformaldehyde under deeply anaesthe-
tized conditions. Their brains were removed and post-fixed
in 10% sucrose/4% paraformaldehyde for 8 h at 4 C˚ and
then placed in 20% sucrose/PBS at 4 C˚ overnight. Using a
cryostat microtome, 25-mm frozen sections were cut for the
8-oxoguanine experiment.
Measurement of antioxidant enzyme activities and
ROS generation
The SOD and GSH-Px activities were assessed using
commercially available kits following the manufacturer’s
instructions. The levels of ROS production in the hippo-
campal tissues were measured fluorimetrically using
DCFH-DA as previously described (17). Briefly, 20 mg
of tissue was pooled in 500 mL of cold lysis buffer (50 mM
Tris–HCl, pH 7.5; 50 mM NaCl; 1 mM EGTA; 10 mM
EDTA; 1 mM NaVO4; 1 mM PMSF, supplemented
with 0.1% v/v Triton X-100 and protease inhibitor cocktail).
The samples were homogenized for 15 s with a sonic
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dismembrator and centrifuged at 10,000 rpm at 4 C˚ for
20 min. The supernatants were filtered through 0.45-mm
hydrophilic filters. The protein concentration of the lysates
was estimated using a BCA Protein Assay Kit. The homo-
genate samples from different groups were incubated with
10 mM DCF-DA at 37 C˚ for 1 h, and the fluorescence intensity
was measured at an excitation wavelength of 485 nm and
emission wavelength of 525 nm. The ROS level was
presented as the percentage of increase with respect to the
control group.
Western blotting
Hippocampal tissue was lysed using ice-cold RIPA buffer
(150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS, 5 mM ethylenediamine tetraacetic acid, 50 mM Tris-
HCl, pH 8.0) supplemented with protease inhibitor cocktail
and then centrifuged at 13,000 rpm for 10 min at 4 C˚. The
supernatant was collected, and the protein concentration
was estimated using a BCA Protein Assay Kit with bovine
serum albumin as the standard. In addition, 30 mg of protein
was loaded into SDS PAGE gels after adding the sample
buffer and boiling. The proteins were then transferred to
nitrocellulose membranes. After transfer, the membranes
were blocked with Tris-buffered saline (TBS) containing
0.1% Tween-20 (TBST) and 5% non-fat milk for 2 h at room
temperature and then overnight at 4 C˚ with the following
primary antibodies: anti-MTH1 (1:500) and anti-b-actin
(1:2000). After washing, the membranes were incubated
with goat radish peroxidase-conjugated secondary antibody
(1:5000), followed by detection using enhanced chemilumi-
nescence. The scanned images of the developed blots were
quantified using densitometry functions in Image-Pro
Express 4.0 software (Media Cybernetics, Inc., Bethesda,
MD, USA).
Immunohistochemical detection of 8-oxoguanine
For the detection of oxidized nuclear DNA in neurons, the
sections were first pretreated in 10 mM Tris–HCl (pH 7.4)
containing 15 mM NaCl and 5 mg/ml DNase-free RNase
for 60 min at 37 C˚ to eliminate cellular RNA. Then, the
RNase-treated sections were incubated in 3 N HCl for
30 min at room temperature to denature the DNA, and the
rinsed sections were immersed in a solution of 3% H2O2 in
methanol/PBS (1:1) for 5 min at room temperature and then
incubated with blocking buffer for 2 h at room temperature,
followed by the primary monoclonal antibody, anti-8-
oxoguanine (1:100), overnight at 4 C˚. After washing with
PBS, the sections were incubated with a goat anti-rat biotin-
conjugated secondary antibody for 1 h, followed by
peroxidase-conjugated streptavidin. Visualization was
performed using 3-3’-diaminobenzidine (DAB). The final
immunoreaction product of DAB was brown-yellow in
color. The sections were washed with PBS, dehydrated in
graded ethanol solutions, cleared in xylene, and cover-
slipped.
Quantitative 8-oxoguanine analysis
All acquired digital images were processed uniformly at a
threshold in gray-scale mode to subtract any background
corresponding to the area without tissue using a Leica
microscope (Leica, Germany). The optical density (OD) in
an area comprising the cytoplasm and nucleus was
determined using the Leica Q550CW Image Analysis
System linked to a Leica microscope. Six adjacent fields of
the CA1 and DG subregions of the hippocampi from each
mouse were selected. The OD value was corrected for
background by subtracting the OD of the white matter on
the same section and averaged. All measurements were
performed under the same optical and light conditions, and
electronic shading correction was performed to compensate
for any unevenness that may be present in the illumination.
Statistical analysis
Data are expressed as the mean ¡ SEM. Differences
between mean values were evaluated by analysis of
variance (ANOVA) followed by post-hoc tests. Statistical
significance was set at p#0.05.
& RESULTS
Morris water maze test
In the Morris water maze test, the swimming speeds of
the mice in the control and OVX groups were 20.9 and
22.2 cm/s, respectively, and there were no significant
differences in the speeds between the groups (data not
shown). The time spent in the target quadrant (explore time)
and the escape latency in the probe test are shown in
Figure 1. The data revealed that OVX-treated animals
exhibited significantly longer escape latency (F(1,19) =
95.31, p,0.001) and less time spent in the target quadrant
(F(1,19) = 76.59, p,0.001) in probe tests compared with the
animals in the control group. a-ZAL administration sig-
nificantly shortened the escape latency (F(1,19) = 19.79,
p,0.001) and lengthened the explore time (F(1,19) = 21.51,
p,0.001) compared with the OVX group, as did the
administration of E2.
Anti-oxidant enzyme activities and ROS generation
in the hippocampus
Our data revealed that the activities of the anti-oxidant
enzymes, including SOD and GSH-Px, were significantly
decreased by 32 and 35%, respectively, in OVX animals
compared with the control group (Figure 2A and B), and
OVX administration resulted in a 1.5-fold increase in the
ROS level relative to the control group (Figure 2C).
However, a-ZAL administration effectively attenuated the
decrease in SOD (a-ZAL versus OVX: F(1,13) = 5.37, p= 0.039)
and GSH-Px (a-ZAL versus OVX: F(1,13) = 5.49, p= 0.037)
and the increase in ROS (a-ZAL versus OVX: F(1,13) = 6.08,
p= 0.031) in OVX mice, as did E2 administration. Although
the effects of a-ZAL on ROS levels, SOD activity, and GSH-
Px activity were less than those of E2, no significant
difference was observed in the enzyme activities and ROS
levels between the E2 and a-ZAL groups.
Neuronal DNA oxidation in the hippocampus
To detect oxidized nuclear DNA in the hippocampi,
immunostaining with antibodies against 8-oxoguanine
was performed. As shown in Figure 3A, low immunor-
eactivity was observed in the nuclei of the control animals.
When antibodies against 8-oxoguanine were applied to
the samples from OVX mice, specific staining of the nuclei
was observed in the CA1 and DG regions of the mice
hippocampi. The average optical density was measured
for the subregions of the hippocampus in the mice, and
the digitized data are shown in Figure 3B. A decrease in 8-
oxoguanine in the CA1 and DG regions of the hippocampus
was observed in mice that received E2 compared with the
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mice treated with OVX alone (F(1,23) = 12.55, p= 0.002 for the
CA1 region, and F(1,23) = 35.56, p,0.001 for the DG region).
The immunohistochemistry assay data also indicated that the
levels of 8-oxoguanine were significantly decreased in the
presence of a-ZAL compared with OVX alone (F(1,23) = 5.77,
p= 0.025 for the CA1 region, and F(1,23) = 29.35, p,0.001 for
the DG region), indicating a low level of oxidative DNA
damage in E2- or a-ZAL-treated mice.
MTH1 protein expression in the hippocampus
We also examined the expression of MTH1, which possesses
the ability to hydrolyze the 8-oxoguanine-containing deoxyr-
ibonucleoside triphosphate, which thereby facilitates DNA
repair and ameliorates oxidized DNA accumulation. Western
blot (Figure 4) analyses indicated that the protein expression of
MTH1 was decreased in the brains from OVX mice (control
versus OVX: F(1,13) = 105.37, p,0.001); however, after E2 or a-
ZAL treatment, these changes were reversed, and they were
significantly different compared with those in the OVX group
(a-ZAL versus OVX: F(1,13) = 81.97, p,0.001, and E2 versus
OVX: F(1,13) = 84.59, p,0.001).
& DISCUSSION
As a neuromodulatory and neuroprotective hormone,
estrogen exerts useful effects associated with the preven-
tion of AD. However, the use of estrogen is imperiled due
to the uncertainty of the increased risk of developing
breast as well as endometrial cancers in women taking
estrogen. Our published data have shown that treatment
with the phytoestrogen a-ZAL can provide protection
against neuronal injury both in vivo and in vitro, but it
yields fewer side effects on the breasts and uterus than
estrogen (7,10). In this study, we demonstrated that a-ZAL
exerted an in vivo improvement in estrogen deficiency-
induced spatial learning and memory impairment. The
neuroprotection afforded by a-ZAL may be mediated
through the regulation of antioxidase activities to improve
oxidative stress and expression of MTH1 to decrease
neuronal oxidative damage, in a manner similar to that
of E2.
The reduction of estrogen levels is an important factor
associated with memory impairment in postmenopausal
women (3-5). OVX animals have been frequently used as a
model of hormone deprivation to study post-menopausal
changes in adult females. Therefore, we used this model to
evaluate the effects of E2 and a-ZAL on the learning and
memory abilities of OVX mice. Results from our study
indicated significant decreases in explore time but
increases in escape latency in OVX animals compared with
control animals. These results are in agreement with those
of Azizi-Malekabadi et al., who demonstrated that ovarian
hormone loss due to ovariectomy in animals impairs water
maze performance (18). However, treatment with E2
significantly improved spatial learning and memory
performance in OVX mice, as did a-ZAL treatment. The
results suggested that the use of a-ZAL may be invaluable
in producing neuroprotective effects similar to E2. The
cognitive deficits correlate well with the increased oxida-
tive stress in ovariectomized animals (19,20); thus, the
observation of the high oxidative stress condition that was
indicated by low SOD and GSH-Px activities and increased
ROS levels in OVX animals in the present study was not
surprising. However, increases in ROS generation and
decreases in antioxidase activities induced by OVX were
significantly attenuated when the animals received supple-
mentation with 17b-E2 or a-ZAL, which thereby decreased
oxidative stress by affecting ROS formation and anti-
oxidant enzyme activities in a beneficial manner to limit
neuronal damage.
In response to oxidative stress, neurons are attacked by
ROS, resulting in widespread oxidative damage. Protein
oxidation may affect neuron function by damaging
enzymes, and lipid oxidation can cause structural mem-
brane damage that may impair cellular stabilization (21,22).
Nucleic acids exposed to ROS also generate oxidative
damage that may lead to neuron dysfunction or even death
Figure 1 - The effects of a-ZAL treatment on escape latency and explore time during the Morris water maze in OVX-induced, memory-
deficient mice. The training began on the 52nd day after a-ZAL or E2 administration. Four training trials each day were conducted for
four consecutive days. The escape latency and explore time from the Morris water maze are shown for the probe test session (the
results from the trial at the 56th). **p,0.01 vs. control group; ##p,0.01 vs. OVX group (n= 10 in each group).
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(23). Several studies have demonstrated that oxidative DNA
damage is significantly increased in neuronal samples from
the brains of AD patients (24,25,12). Moreover, the existing
studies also revealed that the accumulation of oxidative
DNA damage in hippocampal neurons is a trigger for
cognitive dysfunction in AD (26). Therefore, we assayed
the level of 8-oxoguanine, the most commonly analyzed
biomarker of DNA oxidative damage (27). The results of the
8-oxoguanine immunohistochemical analysis performed in
the present study revealed that the optical density of 8-
oxoguanine in the hippocampus increased in OVX mice,
which was partially reversed by E2 or a-ZAL administra-
tion. These results demonstrated the ability of estrogen
to dampen the DNA oxidation process. MTH1 possesses
the specific enzymatic activity necessary to convert the
deleterious 8-oxoguanine-containing deoxyribonucleoside
triphosphate into monophosphates, thus preventing its
misincorporation into DNA and thereby minimizing the
accumulation of oxidized DNA in neurons. Additionally,
MTH1 activity is significantly decreased in AD subjects
(28,29). Therefore, we examined the effect of MTH1 on
estrogen-mediated DNA protection. The Western blot
results revealed a sharp decrease in MTH1 protein expres-
sion levels in OVX mice, whereas E2 and a-ZAL signifi-
cantly inhibited these changes. Obviously, the effect of E2
and a-ZAL on MTH1 expression is beneficial for attenuating
DNA oxidation, which, overall, contributes to improve-
ments in the neuronal dysfunction and cognitive impair-
ments induced by ovarian hormone loss. In addition, we
observed that E2 or a-ZAL administration cannot comple-
tely reverse DNA oxidation. This result suggests that there
are more factors involved in oxidative DNA damage in OVX
animals, and further studies are in progress to address these
possibilities.
In summary, in the current study, we compared the
ability of E2 and a-ZAL to ameliorate memory deficits and
neuronal oxidation due to estrogen deficiency and assessed
whether a-ZAL is associated with the same mechanism for
the amelioration of memory impairment and neuronal DNA
oxidative damage as E2. This study had a few limitations
that should be noted. For example, (1) a wider range of a-
ZAL concentrations should be chosen to investigate the
Figure 2 - E2 and a-ZAL effectively reversed the decrease in anti-oxidative enzyme activities (A and B) and the increase in ROS
generation (C) in hippocampal tissues in OVX mice. The data are expressed as the mean ¡ SEM (n=6 in each group). ** p,0.01 vs.
control group; # p,0.05 and ## p,0.01 vs. OVX group.
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changes in neuronal oxidative damage, and (2) a greater
number of animals should be used to analyze the clinical
efficacy and potential toxicity of a-ZAL. It appears that
a-ZAL may be a potential agent that can be used to prevent
the progression of neurodegenerative disorders related to
estrogen deficiency.
Figure 3 - The effect of E2 and a-ZAL treatment on the levels of 8-oxoguanine in the hippocampi of mice. A. The
immunohistochemical analyses of free-floating sections (25 mm in thickness). The first row shows a lower magnification of the
hippocampus (406), whereas the magnified views of the CA1 (4006) and DG (2006) subregions are shown in the middle and last
rows, respectively. B. Quantification of 8-oxoguanine immunolabeling in the CA1 and DG regions of the hippocampus. n = 4 in each
group. The results represent at least three independent experiments in each animal. **p,0.01 vs. control group; # p,0.05 and
## p,0.01 vs. OVX group.
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